Windward Bio (WWB.US) plans to raise up to 100 million USD in its US IPO; multiple drugs have been licensed to Chinese pharmaceutical companies.
智通财经2026/10/26 07:26Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhihui Finance APP, Switzerland-based clinical-stage biotechnology company Windward Bio Group filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to 100 million USD.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
